SCHEMBL31595672

SCHEMBL31595672

Cc1ccc(Sc2ccccc2NC(=O)C(CCC(=O)O)NC(=O)c2cccc3ccccc23)cc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ L3MBTL1 Q9Y468 3/20 0.46
▸ TDP1 Q9NUW8 2/20 0.46
▸ RAB9A P51151 3/20 0.43
▸ NPC1 O15118 2/20 0.43
▸ PPARG P37231 1/20 0.42
▸ PYGL P06737 1/20 0.42
▸ KDM4E B2RXH2 1/20 0.41
▸ HSD17B10 Q99714 1/20 0.41
▸ CCKBR P32239 2/20 0.40
▸ FNTA P49354 1/20 0.40
▸ FNTB P49356 1/20 0.40
▸ TP53 P04637 1/20 0.38
▸ BLM P54132 1/20 0.38
▸ CTSV O60911 1/20 0.38
▸ CTSL P07711 1/20 0.38
▸ CTSB P07858 1/20 0.38
▸ CTSS P25774 1/20 0.38
▸ LMNA P02545 2/20 0.38
▸ SMN1; SMN2 Q16637 1/20 0.38
▸ ALDH1A1 P00352 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30567233 1.00 L3MBTL1 (0.46) L3MBTL1TDP1RAB9ANPC1PPARG
SCHEMBL25386644 1.00 L3MBTL1 (0.46) L3MBTL1TDP1RAB9ANPC1PPARG
SCHEMBL25386639 1.00 L3MBTL1 (0.46) L3MBTL1TDP1RAB9ANPC1PPARG
SCHEMBL30567142 0.88 L3MBTL1 (0.40) L3MBTL1TDP1RAB9ANPC1PYGL
SCHEMBL31256610 0.80 USP30 (0.43) RAB9ANPC1PPARGPYGLHSD17B10
SCHEMBL25386852 0.77 L3MBTL1 (0.50) L3MBTL1TDP1RAB9ANPC1PPARG
SCHEMBL26264484 0.76 PPARG (0.45) L3MBTL1TDP1RAB9APPARGPYGL
SCHEMBL26264485 0.76 PPARG (0.45) L3MBTL1TDP1RAB9APPARGPYGL
SCHEMBL25387355 0.76 L3MBTL1 (0.54) L3MBTL1TDP1KDM4ETP53BLM
SCHEMBL25387353 0.76 L3MBTL1 (0.54) L3MBTL1TDP1KDM4ETP53BLM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250171404-A1 PCNA INHIBITORS AND USES THEREOF UNITED STATES GOVERNMENT 2025-05-29 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250171404-A1 PCNA INHIBITORS AND USES THEREOF PCNA, MKI67, PCLAF L3MBTL1 1817/4885TDP1 370/4885RAB9A 2797/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback